Bromide

Bromide

SCHEMBL2194103

CCCCOc1ccc([S+]2CCCC2)c2ccccc12.[Br-]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 4/20 0.44
CNR2 P34972 4/20 0.44
GAA P10253 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SLC2A1 P11166 1/20 0.41
CYP2C9 P11712 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HTT P42858 1/20 0.40
HTR1B P28222 4/20 0.39
THRA P10827 1/20 0.38
THRB P10828 1/20 0.38
HTR1D P28221 2/20 0.37
IDO1 P14902 1/20 0.36
LTA4H P09960 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29429149 0.99 CNR1 (0.45) CNR1CNR2GAATDP1L3MBTL1
SCHEMBL106524 0.99 CNR1 (0.45) CNR1CNR2GAATDP1L3MBTL1
Hydrochloric Acid SCHEMBL31108778 0.97 CNR1 (0.44) CNR1CNR2GAATDP1L3MBTL1
SCHEMBL3454520 0.94 CNR2 (0.42) CNR1CNR2GAATDP1L3MBTL1
SCHEMBL2742104 0.93 CNR1 (0.47) CNR1CNR2GAATDP1L3MBTL1
SCHEMBL8737935 0.93 CNR1 (0.47) CNR1CNR2GAATDP1L3MBTL1
SCHEMBL8736285 0.93 CNR1 (0.47) CNR1CNR2GAATDP1L3MBTL1
SCHEMBL702260 0.91 CNR1 (0.44) CNR1CNR2GAATDP1L3MBTL1
SCHEMBL31040506 0.91 CNR1 (0.44) CNR1CNR2GAATDP1L3MBTL1
SCHEMBL13088093 0.90 HTR1B (0.43) CNR1CNR2GAATDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8900791-B2 Actinic ray-sensitive or radiation-sensitive resin composition and method of forming pattern with the composition FUJIFILM CORPORATION (JP) 2014-12-02 US disclosed
US-20110171577-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN WITH THE COMPOSITION FUJIFILM CORPORATION (JP) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171577-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN WITH THE COMPOSITION ARSA, RAD51, ARID2 CNR1 3157/4885CNR2 2671/4885GAA 3220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.